
Current Price | $6.83 | Mkt Cap | $619.0M |
---|---|---|---|
Open | $6.56 | P/E Ratio | 0.00 |
Prev. Close | $6.83 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $6.53 - $7.02 | Volume | 3,367,314 |
52-Wk Range | $4.02 - $43.12 | Avg. Daily Vol. | 4,538,971 |
Current Price | $6.83 | Mkt Cap | $619.0M |
---|---|---|---|
Open | $6.56 | P/E Ratio | 0.00 |
Prev. Close | $6.83 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $6.53 - $7.02 | Volume | 3,367,314 |
52-Wk Range | $4.02 - $43.12 | Avg. Daily Vol. | 4,538,971 |
The best Bull and Bear pitches based on recency and number of recommendations.
It’s got the Boomstick Baby
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about FATE.
Recs
It’s got the Boomstick Baby
Recs
Solid Partner in product and development.
Recs
I admit there was a bit of FOMO going on when I green-thumbed this stock. I think it was the big words that impressed me most. Pluri-potent stem cells. How can you not want to open your wallet and just start dishing it out? While my lack of DD is apparent, I can say that I'm impressed with a couple of things. One is the number of candidates FATE has in the pipeline. The other is that many of these candidates try to attack more than one weakness on a cancer cell. FT596 is a good example. The problem with attacking a single site is that the cell line has a tendency to work around that attack. You may have initial good results, but the surviving cells then produce more cells resistant to that drug. You can use combo therapy or a drug that targets more than one site on the cancer cell. FATE is doing both. I get excited when I see this and tend to green-thumb stuff before I really know enough to make an informed decision. Take that into consideration.
Find the members with the highest scoring picks in FATE.
headyinvestor (< 20) Score: +1,244.40
The Score Leader is the player with the highest score across all their picks in FATE.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
stainsolution | < 20 | 2/17/2016 |
![]() |
5Y | $1.57 | +336.42% | +116.07% | +220.35 | 0 Comment | |
oscillation | 71.09 | 2/11/2016 |
![]() |
5Y | $1.72 | +298.25% | +128.20% | +170.05 | 1 Comment | |
Origin97 | 33.57 | 4/15/2014 |
![]() |
NS | $7.58 | -9.89% | +127.31% | +137.21 | 0 Comment | |
MMCapitalMgmt | 99.96 | 5/11/2015 |
![]() |
5Y | $7.40 | -7.70% | +96.96% | +104.66 | 0 Comment | |
PAGEBOY73 | 98.60 | 6/17/2022 |
![]() |
3Y | $21.42 | -68.11% | +14.06% | +82.17 | 0 Comment | |
![]() |
biznessdoc | 60.95 |
|
![]() |
5Y | $2.57 | +165.76% | +90.37% | +75.38 | 0 Comment |
portefeuille2 | 98.60 | 8/17/2016 |
![]() |
5Y | $2.65 | +157.74% | +91.15% | +66.58 | 0 Comment | |
shonny2 | 23.10 | 2/6/2017 |
![]() |
5Y | $2.87 | +137.98% | +82.07% | +55.91 | 0 Comment | |
Under5 | 67.57 |
|
![]() |
5Y | $4.40 | +55.22% | +61.05% | -5.83 | 0 Comment | |
NoPlaceLikeHome | < 20 | 3/9/2017 |
![]() |
5Y | $4.09 | +67.20% | +75.93% | -8.74 | 3 Comments |
See what the Wall Street professionals think, according to their public statements and filings.